Keywords: Active surveillance; Gleason score; Insignificant prostate cancer; Prostate cancer; PSA
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: NSW; New South Wales; CCR; Central Cancer Registry; SES; socio-economic status; ASR; age-standardised incidence rate; LGA; local government area; ASGC; Australian Standard Geographic Classification; IRSD; Index of Relative Socio-economic Disadvantage; PSA
Keywords: Prostate-specific antigen; PSA; Elderly; Survival; Mortality;
Keywords: Prostate screening; PSA; Metastatic cancer incidence; Mortality reduction;
Keywords: Asthma; Epidemiology; Risk; Late preterm infants; Propensity score; LPT; Late preterm; PSA; Propensity score approach; RCT; Randomized clinical trial;
Keywords: Body mass index; Obesity; Oncology; Prostate cancer; PSA;
Keywords: prostatic neoplasms; neoplasm metastasis; neoplasms; multiple primary; mortality; prognosis; ECOG; Eastern Cooperative Oncology Group; mPCa; metastatic PCa; OS; overall survival; PCa; prostate cancer; PSA; prostate specific antigen; RT; radiation therapy;
Keywords: lymph node excision; treatment outcome; quality of health care; prostatectomy; robotics; LND; lymph node dissection; NCDB; National Cancer Data Base; ORP; open radical prostatectomy; PCa; prostate cancer; PLND; pelvic lymph node dissection; PSA; prostate
Keywords: AUC; area under the ROC curve; BIC; Bayesian information criterion; DRE; digital rectal exam; EMR; electronic medical record; HLS; Hosmer-Lemeshow test statistic; MCMC; Markov Chain Monte Carlo; PBCG; prostate biopsy collaborative group; PCPT; prostate
Keywords: biological markers; prostatic neoplasms; early detection of cancerFDA, U.S. Food and Drug Administration; fPSA, free prostate specific antigen; %fPSA, percent free prostate specific antigen; PCA3, prostate cancer antigen 3; phi, Prostate Health Index; PSA
Keywords: prostatic neoplasms; prostatectomy; prostate-specific antigen; neoplasm recurrence; local; diagnosis; ART; adjuvant RT; BCR; biochemical relapse; cBCR; conventional BCR; iPSA; initial PSA; PSA; prostate specific antigen; RP; radical prostatectomy; RT; rad
Keywords: Androgen deprivation therapy; Prostate cancer; PSA; Radiotherapy; Radiation biology
Keywords: Contraceptive implant; Randomized controlled trial; LARC; Condom use; PSA;
Keywords: Hiperplasia prostática benigna; PSA; Atención PrimariaBenign prostatic hypertrophy; Primary care
Keywords: prostatic neoplasms; delivery of health care; urology; prostate-specific antigen; patient safety; KP; Kaiser Permanente; KPSC; Kaiser Permanente Southern California; PCa; prostate cancer; PSA; prostate specific antigen;
Keywords: prostatic neoplasms; radiotherapy; neoplasm recurrence; local; salvage therapy; prostate-specific antigen; ADT; androgen deprivation therapy; ASTRO; American Society for Radiation Oncology; BCR; biochemical recurrence; EBRT; external beam radiation therap
Keywords: prostate; prostatic neoplasms; SEER program; risk; trendsADT, androgen deprivation therapy; CCI, Deyo-Charlson comorbidity index; NCDB, National Cancer Database; NCIM, noncurative initial management; NOS, not otherwise specified; PCa, prostate cancer; PSA
Keywords: Prostate cancer; Active surveillance; PSA; Risk stratification; Genetic markers; Treatment; Nomogram;
Keywords: blood glucose; diabetes mellitus; prostate-specific antigen; AER; albumin excretion rate; BMI; body mass index; DCCT; Diabetes Control and Complications Trial; EDIC; Epidemiology of Diabetes Interventions and Complications study; HbA1c; hemoglobin A1c; PC
Keywords: prostatic neoplasms; biological markers; risk assessment; molecular diagnostic techniques; ADT; androgen deprivation therapy; AS; active surveillance; Columbia; New York-Presbyterian Hospital, Columbia University; DVU; Delaware Valley Urology, LLC; EBRT;
Keywords: prostatic neoplasms; gonadotropin-releasing hormone; physician's practice patterns; neoplasm recurrence; local; neoplasm metastasis; ADT; androgen deprivation therapy; CADT; continuous androgen deprivation therapy; GnRH; gonadotropin-releasing hormone; IA
Keywords: hematuria; prostatic neoplasms; radiotherapy; urethral stricture; urinary bladder neoplasms; BCa; bladder cancer; BT; brachytherapy; EBRT; external beam radiation therapy; EBRT+BT; combination radiation therapy; PCa; prostate cancer; PSA; prostate specifi
Keywords: AQUA; absolute quantification; ELISA; enzyme-linked immunosorbent assay; FDA; (the US) Food and Drug Administration; iTRAQ; isobaric tags for relative and absolute quantification; LC-MS/MS; liquid chromatography-tandem mass spectrometry; LOD; limit of
Keywords: Prostate cancer; Diagnosis; Biomarkers; Genetics; PSA;
Keywords: adalimumab; biologics; etanercept; infliximab; monitoring; psoriasis; psoriatic arthritis; safety; screening; ustekinumab; AAD; American Academy of Dermatology; ALP; alkaline phosphatase; ALT; alanine transaminase; ANA; antinuclear antibody; AST; aspartat
Keywords: AD; Atopic dermatitis; ADCS; Atopic dermatitis-controlled state; CMF; Cow's milk formula; EHF-C; Extensively hydrolyzed formula-casein; GINI; German Infant Nutritional Intervention; PHF-W; Partially hydrolyzed formula-whey; PSA; Probabilistic sensitiv
Keywords: Gene regulation; Human; PSA; LAT;
Keywords: Diesel; Gasification; Miscanthus; Coal; Feasibility; CO2; CtL; coal to liquids; CBtL; combined coal and biomass to liquids; FT; Fischer-Tropsch; BtL; biomass to liquids; GHG; greenhouse gas; ASU; air separation unit; WGS; water gas shift; LTFT; low-temp
Keywords: Biofuel; Biogas; Biomethane; Carbon footprint; NOx; Particulate matter; AwR; alkaline with regeneration carbon mineralization; BABIU; bottom ash for biogas upgrading; CH4; methane; CHP; combined heat and power; CO2; carbon dioxide; CO2eq; equivalent carbo
Keywords: ACN; Acetonitrile; CE; Capillary electrophoresis; DLLME; Dispersive liquid-liquid microextraction; ECD; Electron-capture detector; FID; Flame-ionization detector; FLD; Fluorescence detector; FPD; Flame-photometric detector; FQ; Fluoroquinolone; HFR; Halog
Keywords: AA; abiraterone acetate; ADT; androgen deprivation therapy; AR; androgen receptor; AR-V; AR splice variant; CRPC; castration-resistant prostate cancer; CTC; circulating tumor cell; CYP; cytochrome P450; FDA; Food and Drug Administration; LBD; ligand-bindi
Keywords: ATRP; atom-transfer radical-polymerisation; Brij700; polyoxyethylene (100) octadecyl ether; CHAPS; 3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate; DBDM; n-dodecyl β-D-maltoside; DCC; N,Nâ²-dicyclohexylcarbodiimide; DLS; dynamic light scatter
Keywords: 3D; three-dimensional; c log P; the calculated log octanol/water partition coefficient; DNA; deoxyribonucleic acid; ATP; adenosine triphosphate; HPT1; intestinal peptide-associated transporter 1; PEPT1; peptide transporter 1; OCT; organic cation transpo
Keywords: AD; anaerobic digestion; AG-MTM; acid-methane mesophilic-thermophilic-mesophilic process; AWWTP; advanced wastewater treatment plant; CHP; combined heat and power; COD; chemical oxygen demand; CSTR; continuous stirred tank reactor; FOG; fats, oil and
Keywords: AGR; acid gas removal; ASU; Air Separation Unit; ATJ; Alcohol-to-Jet fuel; ATR; Autothermal Reformer; CAPEX; capital expenditure; CCU; carbon capture and utilization; FTS; Fischer Tropsch Synthesis; GT; gas turbine; HA; higher alcohols; HC; hydrocarbons;
Keywords: AAP; agglomeration and attrition of particles; Ac; adsorption cycle; Apl.F; application formulated; APOC; analytical proof of concept; AR; air reactor; ARR; auto reduction reactor; BESs; bioelectrochemical systems; BFB; batch fluidized bed; BN; boron nitr
Keywords: CTAB; cetyltrimethyl ammonium bromide; CVD; chemical vapor deposition; EP; electroless plating; GHSV; gas hourly space velocity; GSR; glycerol steam reforming; IUPAC; international union of pure and applied chemistry; MR; membrane reactor; PEMFC; polymer
Keywords: Sperm; Seminal fluid; Differential extraction; Protamines; PSA; Semenogelin;
Keywords: ABC; Ammonium bicarbonate; BSA; Bovine serum albumin; D.A.R.T.'S; Disposable Automated Research Tips; DTT; Dithiotreitol; ELISA; Enzyme-linked immunosorbent assay; FDR; False-discovery rate; FPLC; Fast liquid chromatography; Fc; Constant region of immunog
Keywords: AG-I; type I arabinogalactan; AG-II; type II arabinogalactan; ASGP-R; asialoglycoprotein receptor; CP; citrus pectin; CRD; carbohydrate recognition domain; CSDDS; colon-specific drug delivery system; DF; dietary fiber; DM; degree of methylation; DR; death
Keywords: Biomarkers; Prostate; Screening; TRUS; PSA; PCA3; TMPRSS2:ERG; Prostate Health Index;
Keywords: prostate; prostate-specific antigen; cryosurgery; disease progression; mortality; ASTRO; American Society for Therapeutic Radiology and Oncology; BPFS; biochemical progression-free survival; COLD; Cryo On-Line Database; PSA; prostate specific antigen;
Keywords: Fluorogenic substrate; In situ testing; PSA;
Keywords: prostatic neoplasms; castration-resistant; ADT; androgen deprivation therapy; AUA; American Urological Association; CRPC; castration resistant prostate cancer; FDA; Food and Drug Administration; mCRPC; metastatic castration resistant prostate cancer; PSA;
Keywords: prostate; biopsy; pathology; laboratories; conflict of interest; DRE; digital rectal examination; ISL; independent service laboratory; PSA; prostate specific antigen; UOL; urologist owned pathology laboratory;
Keywords: prostate; prostatic neoplasms; biopsy; prostatectomy; diagnosis; AS; active surveillance; EPE; extraprostatic extension; MP; multiparametric; MRI; magnetic resonance imaging; PSA; prostate specific antibody; PZ; peripheral zone; RP; radical prostatectomy;
Keywords: ACO; super group; specialty network; co-management; PSA
Keywords: ADT, androgen-deprivation therapy; ERSPC, European Randomized Study of Screening for Prostate Cancer; PLCO, Prostate, lung, colorectal and ovarian (trial)Prostate cancer; Saudi Arabia; Metastatic; Early detection; PSA
Keywords: CSE; Clinical Skin Examination; FOBT; Faecal Occult Blood Test; GP; General Practitioner; PSA; Prostate Specific Antigen; SAMScore; Self-Assessment of Melanoma risk Score; Melanoma; Screening; Patient compliance; Clinical pathway; Health belief model;
Keywords: prostate; prostatic neoplasms; prostatectomy; neoplasm recurrence; local; neoplasm grading; BCR; biochemical recurrence; EPE; extraprostatic extension; LNI; lymph node invasion; PSA; prostate specific antigen; PSM; positive surgical margin; RP; radical pr